Journal updates

Prof. Arjan Griffioen and Dr. Andrew Dudley draw attention to outstanding journal content. The papers will be free to access until 4 October 2022.

Discover more about our range of academic oncology titles at Springer Nature here

With great pleasure, we would like to announce that Dr. Andrew Dudley has accepted our invitation to follow on from Prof. Joyce Bischoff as the new co-Editor-in-Chief of the journal. He will work alongside the journal's established Editor Prof. Arjan Griffioen.

Profs. Arjan Griffioen, Joyce Bischoff and Dr Dudley provide their Editor-in-Chief highlights from this issue.

Profs. Arjan Griffioen and Joyce Bischoff provide their Editor-in-Chief highlights from this issue.

Angiopoietin-2 is a relevant predictive factor for ICU direct admission in COVID-19 patients. This result showing an endothelial activation reinforces the hypothesis of a COVID-19-associated microvascular dysfunction.

Read for free: https://bit.ly/2XGxmcg

Guest Edited by Andrew C. Dudley

Together with leading experts in the field we have compiled six focused mini-reviews that cover specific aspects related to the concept of blood vessel co-option by cancer cells. 

Guest Edited by Patrycja Nowak-Sliwinska and Arjan W. Griffioen, this special issue of Angiogenesis focusses on the combination of angiostatic strategies with other treatment modalities.

Abstracts from the 13^th International HHT Scientific Conference, June 12–16, 2019, Rio Grande, Puerto Rico

Abstracts from the 12^th International HHT Scientific Conference, June 8–11, 2017, Dubrovnik, Croatia